β-Elemene Enhances the Sensitivity of Osteosarcoma Cells to Doxorubicin via Downregulation of Peroxiredoxin-1.

OncoTargets and Therapy
Shaochun Zhang, Weichun Guo

Abstract

Doxorubicin (Dox) resistance is a primary obstacle for the treatment of osteosarcoma. Meanwhile, β-Elemene was shown to exhibit an anti-proliferative effect on osteosarcoma cells. However, the role of a combination of Dox with β-Elemene on osteosarcoma cells remains unclear. Thus, this study aimed to investigate the role of the combination of Dox with β-Elemene on the proliferation, apoptosis and oxidative stress of Dox-resistance osteosarcoma cells. CKC-8, EdU staining and flow cytometry assays were used to determine the viability, proliferation and apoptosis of Dox-resistance osteosarcoma cells, respectively. Meanwhile, the expression of antioxidant protein peroxiredoxin-1 (Prx-1) in Dox-resistance osteosarcoma cells was detected with Western blot assay. In this study, the inhibitory effects of Dox on the viability and proliferation of Dox-resistance osteosarcoma cells were significantly enhanced by β-Elemene. In addition, the combination of Dox and β-Elemene markedly induced the apoptosis and oxidative stress in Dox-resistance osteosarcoma cells. Moreover, combination treatment notably downregulated the expression of Prx-1 in Dox-resistance osteosarcoma cells, indicating that combination treatment inhibited the antioxidant c...Continue Reading

References

May 1, 2012·Archives of Pathology & Laboratory Medicine·Nikhil A Sangle, Lester J Layfield
Jun 28, 2012·Journal of Cancer Research and Clinical Oncology·Dan LiangXiuli Zhang
Jan 13, 2015·Journal of Cancer Research and Therapeutics·Sangeeta Rivankar
May 18, 2016·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Lu WangHongli Shan
Nov 4, 2017·Anti-cancer Drugs·Chao ChenXiyun Deng
Apr 29, 2018·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Chao-Yuan TangYang Xiong
Jun 20, 2018·BMC Pharmacology & Toxicology·Pimradasiri SrijiwangsaKesara Na-Bangchang
Jul 12, 2018·International Journal of Cancer. Journal International Du Cancer·Zhongnan YinLixiang Xue
Nov 16, 2018·Cellular and Molecular Life Sciences : CMLS·Ilaria BuondonnoChiara Riganti
Dec 14, 2018·Biochemical and Biophysical Research Communications·Yuan SunBaoping Luo
Dec 28, 2018·OncoTargets and Therapy·Rongxin SunYihe Hu
Jan 9, 2019·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Aug 3, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wen-Qiang CaoXiao-Yan Fu
Aug 9, 2019·BMC Complementary and Alternative Medicine·Zhaoyu FuRui Liang
Sep 6, 2019·Oxidative Medicine and Cellular Longevity·Bruno R B PiresEliana Abdelhay
Oct 9, 2019·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Hamdan S Al-MalkyAbdel-Moneim M Osman
Oct 24, 2019·Biochemical and Biophysical Research Communications·Wanli MaPeng Ren

❮ Previous
Next ❯

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis